KYORIN Holdings (4569) Fundamentals 2026 — P/E 19.4x, Revenue Analysis | SniperIQ
KYORIN Holdings (4569) is a JP-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ¥67.0B, trading at ¥1167.00 on the JPX. This SniperIQ fundamentals page covers KYORIN Holdings's valuation (P/E 19.4x, P/B 0.5x), profitability (net margin 2.7%), revenue (¥126.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is KYORIN Holdings's market cap?
KYORIN Holdings (4569) has a market capitalization of approximately ¥67.0B, trading at ¥1167.00 on the JPX. Market cap moves with the live share price.
What is KYORIN Holdings's P/E ratio?
KYORIN Holdings's trailing twelve-month P/E ratio is 19.4x, with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is KYORIN Holdings?
KYORIN Holdings runs a net profit margin of 2.7%, a gross margin of 40.9%, and an operating margin of 2.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does KYORIN Holdings generate?
KYORIN Holdings reported revenue of ¥126.3B for fiscal year 2025, with net income of ¥3.4B and earnings per share (EPS) of 60.02. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does KYORIN Holdings pay a dividend?
KYORIN Holdings offers a trailing dividend yield of about 4.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is KYORIN Holdings financially healthy?
KYORIN Holdings carries a debt-to-equity ratio of 0.17x and a current ratio of 4.60x, with a market beta of -0.04. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is KYORIN Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For KYORIN Holdings (4569) the key facts are: market cap ¥67.0B, P/E 19.4x, revenue ¥126.3B, 52-week range 1067-1725. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track KYORIN Holdings's full fundamentals live
Get KYORIN Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.